Nuclear factor-kappa B pathway and response in a phase II trial of bortezomib and docetaxel in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
Titel:
Nuclear factor-kappa B pathway and response in a phase II trial of bortezomib and docetaxel in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
Auteur:
Chung, C.H. Aulino, J. Muldowney, N.J. Hatakeyama, H. Baumann, J. Burkey, B. Netterville, J. Sinard, R. Yarbrough, W.G. Cmelak, A.J. Slebos, R.J. Shyr, Y. Parker, J. Gilbert, J. Murphy, B.A.